Manufacturer record
Daffodills Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Daffodills Pharmaceuticals Ltd (Uttar Pradesh) were declared Not of Standard Quality between February 2019 and January 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 18220490, Teneligliptin Tablets I.P. 20mg (ZITEN) (exp Jun 2024). CDTL Hyderabad (CDSCO lab) found it not of standard quality: Dissolution. Listed in the January 2023 alert.
Records by type
4 records linked to Daffodills Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Teneligliptin Tablets I.P. 20mg (ZITEN) | Batch 18220490Mfg Jul 2022 · Exp Jun 2024 | DissolutionDissolution | CDTL HyderabadCDSCO lab | Jan 2023 |
| CIPROFLOXACIN TABLETS I.P. 500 mg | Batch DT-281Mfg Jan 2020 · Exp Jun 2021 | Uniformity of weightUniformity of weight/content | RDTL ChandigarhCDSCO lab | Dec 2020 |
| (CIPROFLOXACIN TABLETS I.P. 500 mg) | Batch DT-042Mfg May 2019 · Exp Oct 2020 | Assay & DissolutionAssay | RDTL ChandigarhCDSCO lab | Jul 2020 |
| Pantoprazole Injection | Batch PZD-046Mfg Jul 2018 · Exp Jun 2020 | Particulate ContaminationParticulate matter | Drugs Control Department, AssamCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.